Allergan fell$. 45 or. 4 percent, to $101.03. Baxter International Inc. rose$. 06 or. 1 percent, to $70.79. Boston Scientific Corp. fell$. 09 or. 9 percent, to $9.55.
Shares of Medtronic Inc. slipped Tuesday, a day after the medical device maker announced findings from independent reviews of studies of its Infuse bone graft.
Allergan fell$. 41 or. 4 percent, to $101.07. Baxter International Inc. rose$. 11 or. 2 percent, to $70.84. St. Jude Medical Inc. fell$. 03 or. 1 percent, to $45.63.
Allergan rose$. 34 or. 3 percent, to $101.48. Baxter International Inc. rose$. 13 or. 2 percent, to $70.73. Boston Scientific Corp. rose$. 13 or 1.4 percent, to $9.64.
AUDUBON, Pa.-- Spinal implant manufacturer Globus Medical may have to pay $16 million after a jury decided that three of its products infringed on the patents held by DePuy Synthes Products LLC, a unit of Johnson& Johnson Inc.. Globus said that the jury in the U.S. District Court in Delaware made its decision Monday.
Allergan rose$. 72 or. 7 percent, to $101.86. Baxter International Inc. rose$. 09 or. 1 percent, to $70.69. Boston Scientific Corp. rose$. 20 or 2.1 percent, to $9.71.
Allergan rose$. 99 or 1.0 percent, to $102.13. Baxter International Inc. rose$. 39 or. 6 percent, to $70.99. Medtronic rose$. 39 or. 7 percent, to $53.31.
Allergan fell$. 39 or. 4 percent, to $101.14. Baxter International Inc. fell$. 15 or. 2 percent, to $70.60. Boston Scientific Corp. fell$. 07 or. 7 percent, to $9.51.
Secretary of State John Kerry to press India to reverse government actions they said threaten millions of U.S. jobs in pharmaceutical, information technology and creative industries.
Allergan fell$. 56 or. 6 percent, to $100.97. Baxter International Inc. rose$. 08 or. 1 percent, to $70.83. Boston Scientific Corp. fell$. 07 or. 7 percent, to $9.51.
Allergan rose$. 13 or. 1 percent, to $101.66. Baxter International Inc. rose$. 35 or. 5 percent, to $71.10. Boston Scientific Corp. rose$. 04 or. 4 percent, to $9.62.
June 13- The U.S. Food and Drug Administration on Thursday urged medical device makers and medical facilities to upgrade security protections to protect against potential cyber threats that could compromise the devices or patient privacy.
The Food and Drug Administration wants makers of medical devices to design future products to prevent hackers from targeting them and disrupting patient care. A draft of the agency's recommendations _ what the FDA calls guidance _ was posted on its website Thursday.
Allergan rose $1.29 or 1.3 percent, to $101.53. Johnson& Johnson rose $1.17 or 1.4 percent, to $84.91. Medtronic rose $1.17 or 2.3 percent, to $52.78.
The FDA issued an advisory that manufacturers, hospitals and patients need to protect themselves better from the introduction of malware in medical equipment and unauthorized access to settings that control devices.
Allergan fell$. 05 or percent, to $100.19. Baxter International Inc. rose$. 61 or. 9 percent, to $70.36. Boston Scientific Corp. rose$. 08 or. 8 percent, to $9.50.
Allergan fell$. 24 or. 2 percent, to $100.01. Baxter International Inc. fell$. 01 or percent, to $69.74. Boston Scientific Corp. fell$. 03 or. 3 percent, to $9.39.
MURRAY HILL, N.J.-- Medical device maker C.R. Bard said Wednesday that its board authorized the repurchase of $500 million in company common stock. The new stock buyback is in addition to the $30 million authorization remaining under the company's June 2012 buyback plan. Shares of C.R. Bard Inc. rose 40 cents to close at $105.11.
Baxter International Inc. fell$. 02 or percent, to $69.75. Boston Scientific Corp. fell$. 02 or. 2 percent, to $9.42. Medtronic fell$. 46 or. 9 percent, to $51.61.
Allergan rose$. 49 or. 5 percent, to $100.88. Baxter International Inc. rose$. 15 or. 2 percent, to $69.92. Boston Scientific Corp. fell$. 03 or. 3 percent, to $9.42.
DuckDuckGo CEO Gabriel Weinberg says web traffic on his search engine, billed as an alternative to Google that doesn't store your private information, surged 33 percent after the NSA news broke. Weinberg discusses the model of his search engine, and how the company makes money.
Wednesday, 19 Jun 2013 | 6:31 AM ETJohn Silvia, Wells Fargo Securities, and Barbara Marcin, Gabelli Dividend Income Fund, discuss whether investors should reconsider allocating their portfolios as the Fed wraps up its two-day policy meeting.
Wednesday, 19 Jun 2013 | 8:53 AM ETKen Langone, Invemed Associates chairman and president, called Fed Chairman Ben Bernanke a "lame duck."